These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 21536989

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT)--study protocol.
    Vaclavik J, Sedlak R, Plachy M, Navratil K, Plasek J, Husar R, Kocianova E, Taborsky M.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Jun; 155(2):143-8. PubMed ID: 21804623
    [Abstract] [Full Text] [Related]

  • 6. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K, Ogihara T, Saruta T, Kuramoto K, REZALT Study Group.
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
    Oigman W, Gomes MA, Pereira-Barretto AC, Póvoa R, Kohlmann O, Rocha JC, Nobre F.
    Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
    [Abstract] [Full Text] [Related]

  • 8. Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial.
    Oxlund CS, Henriksen JE, Tarnow L, Schousboe K, Gram J, Jacobsen IA.
    J Hypertens; 2013 Oct; 31(10):2094-102. PubMed ID: 24107738
    [Abstract] [Full Text] [Related]

  • 9. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U, García de Vinuesa S, Goicoechea M, Macías N, Santos A, Perez de Jose A, Verde E, Yuste C, Luño J.
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [Abstract] [Full Text] [Related]

  • 10. Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment).
    Krieger EM, Drager LF, Giorgi DMA, Pereira AC, Barreto-Filho JAS, Nogueira AR, Mill JG, Lotufo PA, Amodeo C, Batista MC, Bodanese LC, Carvalho ACC, Castro I, Chaves H, Costa EAS, Feitosa GS, Franco RJS, Fuchs FD, Guimarães AC, Jardim PC, Machado CA, Magalhães ME, Mion D, Nascimento RM, Nobre F, Nóbrega AC, Ribeiro ALP, Rodrigues-Sobrinho CR, Sanjuliani AF, Teixeira MDCB, Krieger JE, ReHOT Investigators.
    Hypertension; 2018 Apr; 71(4):681-690. PubMed ID: 29463627
    [Abstract] [Full Text] [Related]

  • 11. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of spironolactone therapy in patients with true resistant hypertension.
    de Souza F, Muxfeldt E, Fiszman R, Salles G.
    Hypertension; 2010 Jan; 55(1):147-52. PubMed ID: 19858405
    [Abstract] [Full Text] [Related]

  • 14. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 15. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project.
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [Abstract] [Full Text] [Related]

  • 16. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P, Vasconcelos N, Santos I, Almeida L, Nazaré J, Carmona J.
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Renal denervation in moderate treatment-resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.